 Greg is a strong and welcomed addition to our board, said James Sapirstein, CEO of AzurRx BioPharma. I am excited to join the AzurRx Board with its compelling potential synthetic alternative to PERT therapy, said Mr. Oakes. I look forward to helping the Company realize the full commercial 